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Abstract
Background: Hepcidin serves as a major regulator of systemic iron metabolism and immune function. Airway
epithelial cells have an extensive interface with the environment, and so must be able to respond locally to the
presence of particulates, infection, and inflammation. Therefore, we hypothesized that hepcidin is expressed in
airway epithelial cells and is regulated by early phase cytokines.
Methods: Primary, differentiated human bronchial epithelial (NHBE) cells were used to assess hepcidin gene
expression in response to IFN-g, TNF-a, IL-1b, and IL-6, as well as to LPS + CD14. The role of the Janus Kinase-
signal transducer and activator of transcription (JAK-STAT) pathway in IFN-g-mediated hepcidin production was
assessed by measuring JAK2 phophorylation and STAT1 nuclear translocation. Inductively coupled plasma mass
spectroscopy (ICP-MS) was used to determine whether hepcidin altered iron transport in either NHBE cells or
primary alveolar macrophages.
Results: We demonstrate that differentiated human airway epithelial cells express hepcidin mRNA and that its
expression is augmented in response to IFN-g via activation of STAT1. However, while IFN-g induced hepcidin gene
expression, we were not able to demonstrate diminished expression of the iron export protein, ferroportin (Fpn), at
the cell surface, or iron accumulation in airway epithelial in the presence of exogenous hepcidin.
Conclusion: These data demonstrate that airway epithelial cells express hepcidin in the lung in response to IFN-g.
The presence of hepcidin in the airway does not appear to alter cellular iron transport, but may serve as a
protective factor via its direct antimicrobial effects.
Background
Hepcidin is a key regulator of systemic and cellular iron
homeostasis. The 25-amino acid peptide is secreted pre-
dominantly by the liver in response to anemia, hypoxia,
and inflammation [1-4]. Systemically, hepcidin coordi-
nates iron absorption and export by binding to the iron
export protein, ferroportin (Fpn), which is then phos-
phorylated, internalized, and ubiquitinated. The subse-
quent degradation of Fpn in the lysosomes leads to
decreased cellular iron export and intracellular iron
retention [5-8]. Locally, hepcidin is expressed in numer-
ous cell types including macrophages, myocytes, and
neurons, where it responds in a tissue specific manner
to alterations in iron content, changes in oxygen ten-
sion, and the presence of inflammation [1,7,9-11].
In addition to its primary role in iron metabolism,
hepcidin also plays an important role in immune func-
tion. Iron is an essential nutrient for growth and devel-
opment of all organisms, and its availability closely
correlates with bacterial virulence [12-14]. Hepcidin
modulates immune function in part by its ability to
decrease iron absorption and serum iron content in
response to infection and inflammation in order to
reduce the iron available to pathogens. Hepcidin also
protects against infection via its ability to attack patho-
gens directly [15]. Initial identification of hepcidin, or
liver-expressed antimicrobial peptide (LEAP-1), was
based on the presence of structural features and a spec-
trum of antimicrobial activity that are very similar to
the defensin peptide family [3,15]. Antimicrobial pep-
tides serve as an important component of the innate
immune system and are predominantly expressed at
epithelial surfaces where interactions with the outside
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any medium, provided the original work is properly cited.environment exist and therefore constitute the first line
of defense against invading pathogens [16].
T h el u n g sp r o v i d ea ne x t e n s i v ei n t e r f a c ew i t ht h e
environment, and therefore, are continually exposed to
inhaled iron-containing particulates and airborne micro-
bials. As the first line of defense, airway epithelial cells,
together with macrophages, must provide a coordinated
system of defense. An essential component of this is to
prevent the unregulated access of host metal to
microbes [17]. The pattern of regulation of the iron
export protein, Fpn, in the lung suggests that it serves
an iron detoxification function rather than the nutritive
purpose of iron transporters in the duodenal epithelial
cells [18]. Given the lungs’ extensive interface with the
e n v i r o n m e n ta n di t ss u b s e q u e n tn e e df o rl o c a lc o n t r o l
of iron accessibility and immune function, we hypothe-
sized that hepcidin is expressed by airway epithelial
cells. We further postulated that hepcidin expression is
coordinated by pro-inflammatory cytokines to provide a
localized mechanism to augment the antimicrobial
defense of the airway.
Methods
Cell culture
Primary human bronchial epithelial (NHBE) cells from
three normal donors were obtained from Lonza (Walk-
ersville, MD) and expanded to passage-3 in bronchial
epithelial cell basal medium (BEBM). Cells were plated
on collagen-coated (rat-tail collagen, type I, 50 ug/ml/
0.02 N acetic acid) Transwell
® filter supports (24.5
mm, 0.45 μm; Corning Costar, Cambridge, MA) at a
d e n s i t yo f1×1 0
5 cells/filter in a 6-well culture plate
format and maintained in BEGM medium as a 1:1
mixture of BEBM and Dulbecco’s Modified Eagle Med-
ium with high glucose (DMEM-H) containing hydro-
cortisone (0.5 μg/ml), epinephrine (0.5 μg/ml), insulin
(5 μg/ml), triiodothyronine (6.5 ng/ml), transferrin (10
μg/ml), gentamicin (50 mg/ml), amphotericin-B (50
ng/ml), bovine pituitary extract (13 mg/ml), bovine
serum albumin (1.5 μg/ml), nystatin (10,000 U), hEGF
(25 ng/ml), and retinoic acid (5 × 10
-5 M) as pre-
viously described [19]. Fresh medium was provided
every 48 hours. Upon reaching 75% confluence, the
apical medium was removed and the cells maintained
at air-liquid interface (ALI) until they achieved uni-
form differentiation into mucociliary epithelium after
approximately 14 days post ALI.
Alveolar macrophages were acquired from healthy,
nonsmoking volunteers (18-40 years of age) by fiber-
o p t i cb r o n c h o s c o p yw i t hb r o n c h o a l v e o l a rl a v a g e .T h e
protocol and consent form were approved by the Uni-
versity of North Carolina School of Medicine Commit-
tee on the Protection of the Rights of Human Subjects.
The fiber-optic bronchoscope was wedged into a
segmental bronchus of the lingula and then the right
middle lobe. Aliquots of sterile saline were instilled,
immediately aspirated, and centrifuged. Macrophages
from aliquots were pooled and washed twice. Incuba-
tions were in RPMI-1640 (Invitrogen, Carlsbad, CA,
USA) supplemented with 10% fetal calf serum (FCS;
Invitrogen) and gentamicin solution (20 μg/ml; Sigma,
St. Louis, MO, USA).
In vitro exposure
Differentiated NHBE cells were exposed apically to
Hank’s balanced salt solution (HBSS) as control; lipopo-
lysaccharide (LPS, Escherchia coli 055:B5/L 4005; 100
μg/ml; Sigma, St. Louis, MO) and CD14 (250 ng/ml;
Cell Sciences, Canton, MA); cytomix (IL-1b,1 0 0n g / m l ,
Fitzgerald Industries, Concord, MA; TNF-a,1 0 0n g / m l ;
IFN-g,1 0 0n g / m l ,R & DS y s t e m s ,M i n n e a p o l i s ,M N ) ;o r
IL-6 (100 ng/ml; R&D Systems). These doses have pre-
viously been demonstrated to significantly alter regula-
tion of iron transport [20]. Absence of toxicity with this
dosing was verified using measurement of LDH release.
The cells were exposed for 1 hour, the reagent removed,
and the cells rinsed with HBSS. Cells were harvested for
measurement of RNA expression 2, 6, or 24 hours after
exposure or for JAK2 activation or STAT1 phosphoryla-
tion 15, 60, or 120 minutes after exposure.
Additional cells were pretreated with an inhibitor of
JAK2 phosphorylation, AG490 (10 μM; Calbiochem, San
Diego, CA) for 1 hour followed by treatment with IFN-g
for 1 hour. Cells were harvested for measurement of
RNA expression 24 hours after exposure. The role of
IL-6 was measured by pre-treating differentiated NHBE
cells with a soluble IL-6 receptor (IL-6sR, 1 μ/ml; R&D
Systems) for one hour prior to treatment with either
IFN-g or IL-6 for an additional hour. Cells were har-
vested for measurement of RNA expression 2 or 24
hours after exposure.
RNA isolation and RT-PCR analysis
Total RNA was isolated from NHBE cells by RNeasy
®
(Qiagen, Valencia, CA). Briefly, cells were rinsed with
HBSS and immediately lysed and homogenized in guani-
dine isothiocyanate (GITC)-containing buffer, precipi-
tated by ethanol, bound on a column, washed, and
eluted with water. Following reverse transcription of
total RNA, the resulting cDNA was amplified by Real
Time PCR (ABI Prism 7700 Sequence Detector System,
Applied Biosystems, Foster City, CA). Primers were cho-
sen to span introns to minimize genomic amplification.
The hepcidin primer pair and fluorescent probes were
designed and produced by Applied Biosystems (acces-
sion no. NM_021175). 18S primer pair and fluorescent
probe (TaqMan
® Ribosomal RNA Control Reagents)
were obtained from Applied Biosystems. IL-6 primer
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lowing sequences: Forward: 5’ GGT ACA TCC TCG
ACG GCA TCT 3’; Reverse: 5’ GTG CCT CTT TGC
TGC TTT CAC 3’;P r o b e :5 ’ TGT TAC TCT TGT
TAC ATG TCT CCT TTC TCA GGG CT 3’. Relative
quantification of hepcidin gene expression by Real Time
PCR was performed by fluorogenic amplification of
cDNA using a TaqMan Universal PCR Master Mix
(Applied Biosystems). Relative quantification of hepci-
din, IL-6, and 18s was based on standard curves pre-
pared from the serially diluted cDNA of primary
macrophages for hepcidin and BEAS2B cells for IL-6
and 18s. The abundance of hepcidin and IL-6 mRNA in
each sample was standardized against that of 18s rRNA.
Isolation of total cellular protein
Cells were scraped and lysed with RIPA lysis buffer (1%
Igepal, 0.5% deoxycholate, 0.1% SDS/PBS, pH 7.4) con-
taining protease (Invitrogen,) and phosphatase inhibitors
(Sigma). Cells were sheared through a 22-gauge needle
and the cellular debris was pelleted by centrifugation at
14,000 × rpm for 5 minutes. The supernatant was
removed and protein content determined using the
Lowry DC Protein Assay (BioRad, Hercules, CA).
Isolation of nuclear protein
NHBE cells were rinsed with ice cold 1x PBS, scraped
into cytoplasmic extraction buffer (CEB; Tris-HCl 0.01
M, pH 7.9, KCl 0.06 M, EDTA 0.001 M, DTT 0.001 M,)
with proteases and phosphatase inhibitors and incubated
on ice for 15 minutes. Igepal was added to a final con-
centration of 0.1% and the samples were vortexed and
spun at 14,000 × rpm for 1 minute at 4°C. The cell pel-
let was washed with CEB buffer and spun as above. The
pellet was incubated in nuclear extraction buffer (NEB;
Tris-HCL, pH 8.0 0.02 M, NaCl 0.4 M, MgCl2 0.0015
M, EDTA 0.0015 M, DTT 0.001 M, glycerol 25%) with
proteases and phosphatase inhibitors for 10 minutes and
spun at 14,000 × rpm for 5 minutes at 4°C. The nuclear
fraction was assayed with Lowry DC reagent.
Biotinylation
Two hours after treatment with hepcidin peptide or 24
hours after treatment with IFN-g, NHBE cells were
rinsed three times with ice cold 1x PBS, pH 8.0. EZ-
Link
®. Sulfo-NHS-LC-Biotin (500 ul, 2 mM in 1x cold
PBS; Pierce Biotechnology, Rockford, IL) was added to
each well and incubated at room temperature for 30
minutes. After incubation, the Biotin link was aspirated
and the cells were washed three times with cold 10 mM
glycine/1xPBS. Lysis buffer (0.05% Triton-X, 1 mM
vanadium sulfate oxide, 1x PBS, pH 7.4 with anti-pro-
teases) was added to each well and the cells removed by
scraping. After gentle centrifugation to pellet debris, the
cell supernatant was collected and concentration deter-
mined by Lowry DC protein assay (BioRad). The lysate
concentration was standardized before SoftLink™ Soft
Release Avidin Resin (100 ul/0.6 mg; Promega, Madison,
WI) addition and incubated by end-over-end mixing for
3 hours at 4°C. Resin was allowed to settle and the
lysate removed as above. The resin was then rinsed
twice with sodium phosphate buffer (0.1M Na2HPO4,
pH 7.2) with end-over-end mixing for 10 minutes. Bio-
tinlyated surface proteins were eluted with 5 mM biotin
(2x biotin/1x resin) by end-over-end mixing overnight at
4°C. Resin was allowed to settle and the protein
removed with a 1 ml/27G syringe.
Western blot analysis
Protein concentrations were equalized and loaded with
1X laemmli buffer (75 mM Tris-HCl, pH 6.8, 8% gly-
cerol, 6% SDS, 9% b-mercaptoethanol, 0.05% bromophe-
nol blue), separated by SDS-polyacrylamide gel
electrophoresis, and transferred to a PVDF membrane.
Membranes were blocked with 5% (wt/vol) blotting
grade milk in TBST (0.05 M Tris, 0.138 M NaCl, 0.0027
M KCl pH 8.0, 0.05% Tween 20) for 1 hour at room
temperature. Membranes were rinsed in TBST and
incubated with the appropriate primary antibody
∝-JAK2, ∝-phos-JAK2, or ∝-phos-STAT1(Ser) (1:1000,
1:2000, or 1:1000, respectively; Cell Signaling, Danvers,
MA); ∝-ferroportin (1:1000; generously provided by J.
Kaplan, University of Utah), ∝-b-actin (1:20,000, Sigma,
St.Louis MO) or ∝-tubulin (1:1000; Sigma) in 5% BSA
or milk/TBST, overnight at 4°C. Antigen-antibody com-
plexes were incubated with horseradish peroxidase -
conjugated goat anti-rabbit IgG or goat anti-mouse IgG
secondary (1:2000) for 1 hour in 5% milk/TBST at room
temperature, rinsed, and detected using enhanced che-
miluminescence (ECL, GE Healthcare, Piscataway, NJ).
Both pre-stained and biotinylated markers were used to
confirm transfer and molecular weight, respectively.
Equal loading of protein was confirmed using Ponceau-
S solution (Sigma). Expression was quantified using den-
sitometry (GS-750, BioRad, Hercules, CA).
Inductively coupled plasma mass spectroscopy (ICP-MS)
Cellular iron transport was measured by ICP-MS in dif-
ferentiated NHBE cells at ALI and in alveolar macro-
phages. Cells were loaded with
57Fe by incubating the
cells in 100 μM
57ferric ammonium citrate (FAC) for
four hours. The cells were washed and media replaced.
Cells were then treated with hepcidin peptide (1 μM;
Peptide Institute, Osaka, Japan) for 20 hours. Media was
removed and the cells washed and scraped into 3 N
HCl/10% trichloroacetic acid. After hydrolysis at 70°C
for 24 hours,
57Fe concentration in the acid lysate was
quantified on a Perkin Elmer Elan 6000 inductively
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as an internal standard.
Statistical analysis
Statistical analysis was performed using Prism 4.0
(GraphPad Software, Inc., San Diego, CA). Expression
data are displayed as fold change over control and iron
transport data as the mean ratio of
57Fe/
56Fe ± standard
error (SE) (n = 4, unless otherwise specified). All experi-
ments were performed at least in duplicate using two
separate cell donors. Differences between multiple
groups were compared using one-way analysis of var-
iance (ANOVA) followed by Tukey’s multiple compari-
son post hoc test. Two-way ANOVA was used to assess
the effect of the response over time. Two-tailed tests of
significance were employed. Significance was assumed at
P < 0.05.
Results
Hepcidin is expressed in airway epithelial cells and is
regulated by IFN-g
To determine whether hepcidin is expressed locally in
airway epithelial cells and is regulated in response to
pro-inflammatory stimuli, we exposed differentiated
NHBE cells to LPS (100 μg/ml) and CD14 (250 ng/ml)
(the latter was employed to augment the response of the
airway epithelial cells to LPS) [21], or to a mixture of
pro-inflammatory cytokines (cytomix: TNF-a, IL-1b and
IFN-g (100 ng/ml each)). Changes in hepcidin mRNA
levels were measured using Quantitative Real Time
PCR. Constitutive expression of hepcidin mRNA was
low at baseline but increased by six-fold in the presence
of the pro-inflammatory cytokines (figure 1A) with a
peak effect seen at 6 hours and a return to baseline 24
hours after exposure (figure 1B). No change in hepcidin
mRNA expression was evident after exposure to LPS
and CD14.
To better characterize the regulation of hepcidin by
pro-inflammatory cytokines, NHBE cells were exposed
individually to TNF-a, IL-1b, or IFN-g. Hepcidin mRNA
expression was found to increase after exposure to IFN-
g (figure 1C); with no significant effect by either TNF-a
or IL-1b on hepcidin mRNA levels. The magnitude of
change due to IFN-g at 6 hours was essentially the same
as that observed after cytomix. However, despite the
return to baseline after exposure to cytomix, cells
exposed to IFN-g alone demonstrated a continued
increase in hepcidin gene expression 24 hours after
exposure (figure 1D).
Regulation of hepcidin by IFN-g is mediated via STAT1
Signaling via the IFN-g receptor requires phosphoryla-
tion of the associated tyrosine kinases 1 and 2 which
then mediate phosphorylation and activation of STAT1.
Therefore, to determine the role of the JAK-STAT path-
way in IFN-g-induced hepcidin expression, we measured
phosphorylated JAK2 in the presence and absence of
IFN-g in differentiated NHBE cells. Significant JAK2
phosphorylation occurred within 15 minutes of exposure
to IFN-g with continued activation through the 120
minute exposure (figure 2A). Moreover, increased phos-
phorylated STAT1 was evident in the nucleus of NHBE
cells 15 minutes after exposure to IFN-g (figure 2B). To
more directly link the activation of the JAK-STAT1
pathway with regulation of hepcidin by IFN-g,w ep r e -
treated NHBE cells with AG490, an inhibitor of JAK2
phosphorylation. Inhibition of JAK2 phospohorylation
significantly attenuated hepcidin induction in these cells
24 hours after exposure to IFN-g (figure 2C).
IFN-g induces hepcidin expression independently of IL-6
IL-6 mediates systemic hepcidin expression and can be
induced by IFN-g [22,23]. To evaluate whether IL-6
plays a role in IFN-g-mediated hepcidin expression, we
first confirmed that IL-6 induces hepcidin gene expres-
sion in differentiated NHBE cells. We found that hepci-
din mRNA expression rapidly increased with a peak
Figure 1 Hepcidin gene expression is increased in airway
epithelial cells after exposure to pro-inflammatory cytokines.
NHBE cells, grown at ALI, were exposed to LPS (100 μg/ml) + CD14
(250 ng/ml) or to cytomix (TNF-a, IL1-b, and IFN-g (100 ng/ml,
each)) for 1 hr and harvested after 6 hrs (A) or after 2, 6, and 24 hrs
to establish a time response curve (B). Additional cells were exposed
to individual cytokines, TNF-a, IL1-b, and IFN-g for 1 hr and
harvested after 6 hrs (C) or IFN-g for 1 hr and harvested after 2, 6,
and 24 hrs and compared to time-based controls (D). Total RNA
was isolated using RNeasy
® and reversed transcribed. Quantitative
PCR was performed using TaqMan polymerase. Fluorescence was
detected on an ABI Prism 7700 sequence detector (Applied
Biosystems). Relative abundance of hepcidin was normalized to 18s
and expressed as fold induction over control ± SE and represent at
least n = 4. * P < 0.001,
#P < 0.05 relative to time-based HBSS
control cells.
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and return to baseline after 6 hours. To assess whether
IFN-g mediates hepcidin production by augmenting IL-6
expression, we pre-treated NHBE cells with an IL-6
receptor antibody prior to exposure to IFN-g or IL-6 to
block signaling through the IL-6 pathway. The mRNA
levels measured 2 hours after exposure indicated that
Figure 2 IFN-g activates the JAK-STAT pathway, which
contributes to hepcidin induction. NHBE cells, grown at ALI, were
exposed to IFN-g (100 ng/ml) for 15, 60, and 120 minutes. Whole
cell protein lysates (40 μg) were separated by SDS-polyacrylamide
gel electrophoresis (7.5%) followed by immunoblotting using a
phos-JAK2 antibody (Cell Signaling, Danvers, MA; 1:2000) then
stripped and re-probed using a JAK2 antibody (Cell Signaling,
1:1000) to assess total JAK2 expression (A). Nuclear protein extracts
(5 μg) from additional NHBE cells exposed to IFN-g for 15 minutes
were probed with a phos-STAT1 antibody and standardized to a-
tubulin (B). NHBE cells pre-treated with a JAK2 inhibitor (AG490, 10
μM) prior to exposure to IFN-g were harvested 24 hrs following
exposure. RNA was isolated, reversed transcribed, and quantitative
PCR performed. Relative abundance of hepcidin was normalized to
18s and expressed as fold change over induction ± SE and
represent n = 4. * P < 0.001 relative to HBSS control cells,
#P < 0.05
relative to IFN-g stimulated cells. Figure 3 IL-6 increases hepcidin gene expression in airway
epithelial cells but does not contribute to IFN-g induced
hepcidin expression. NHBE cells, grown at ALI, were exposed to IL-
6 (100 ng/ml) for 1 hour and harvested after 2, 6, and 24 hrs (A).
Additional NHBE cells were pre-treated with an IL-6 soluble receptor
antibody (IL-6sR; 1 μg/ml) for 1 hr prior to exposure to either IFN-g
or IL-6, then harvested after 2 hrs (B) and 24 hrs (C). Hepcidin gene
expression was measured by real time PCR, normalized to 18s, and
expressed as fold induction over control ± SE (n = 4). * P < 0.001
relative to control;
#P < 0.05 relative to IL-6 stimulated cells.
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mediated hepcidin expression, it did not affect expres-
sion mediated by IFN-g (figure 3B). Maximal induction
of hepcidin by IFN-g 24 hours after exposure likewise
was not affected in the presence of the IL-6 receptor
antibody (figure 3C).
Hepcidin does not decrease Fpn expression at the cell
surface
Systemically, the hepcidin protein acts to limit cellular
iron export by internalizing and degrading the iron
export protein, Fpn, which results in intracellular iron
accumulation. We examined the effect of increased hep-
c i d i no nc e l ls u r f a c ee x p r e s s i o no fF p ni nN H B Ec e l l s
treated with either IFN-g for 24 hours or exogenous
hepcidin for 2 hours at a concentration consistent with
measurements of serum hepcidin in patients with ane-
mia of chronic disease or iron overload [24]. Using sur-
face biotinylation and avidin precipitation, we found a
small, though not statistically significant decrease in cell
surface Fpn protein expression in the presence of either
IFN-g or hepcidin. This suggests that although hepcidin
is present in NHBE cells and is regulated by inflamma-
tory cytokines, it does not appear to significantly alter
cell surface expression of the iron export protein within
these experimental conditions (figure 4).
Hepcidin does not alter iron transport in the airway
We next evaluated the functional impact of increased
hepcidin expression on cellular iron content. Differen-
tiated NHBE cells were loaded with
57Fe for 4 hours,
then treated with exogenous hepcidin for 20 hours. This
duration of treatment was chosen because the uptake of
iron by NHBE cells after exposure to Fe
3+ typically is
accomplished over 4 hours with subsequent cellular
export over the next 16 hours [18]. We found that, con-
sistent with minimal internalization of Fpn with both
IFN-g and hepcidin, iron did not accumulate intracellu-
larly in the presence of exogenous hepcidin (figure 5A).
Because iron metabolism in the lung requires coordina-
tion between epithelial cells and macrophages [25], we
next evaluated whether hepcidin released by airway
epithelial cells could impact iron transport in
Figure 4 Fpn surface expression is unchanged in the presence
of exogenous hepcidin or IFN-g. NHBE cells, grown at ALI, were
pre-treated with either IFN-g for 24 hours prior or exogenous
hepcidin peptide (1 μM) for 2 hours prior to biotinylation of cell
surface proteins and cell harvest. Equal quantities of protein (300
μg) were separated by SDS-polyacrylamied gel electrophoresis (12%)
followed by immunoblotting using an Fpn antibody (1:1000,
generously provided by J. Kaplan, University of Utah) and
standardized to Coumassie staining.
Figure 5 Exogenous hepcidin does not alter iron transport in
NHBE cells or alveolar macrophages. Differentiated NHBE cells (A)
or alveolar macrophages (B) were loaded with
57Fe for 4 hours,
followed by treatment with exogenous hepcidin peptide (1 μM) for
an additional 20 hours. Cells were washed and scraped into 3 N
HCl/10% trichloroacetic acid. After hydrolysis at 70°C for 24 hours,
57Fe was quantified. The quantity of exogenous
57Fe was compared
to the naturally occurring
56Fe and showed no change in either the
airway epithelial cells or alveolar macrophages treated with
exogenous hepcidin peptide.
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obtained from healthy volunteers by bronchoscopy and
loaded with
57Fe as described for NHBE cells. The
macrophages were then incubated with hepcidin peptide
for an additional 20 hours. No change in intracellular
iron content was seen in macrophages treated with hep-
cidin (figure 5B).
Discussion
Hepcidin is a major regulator of both iron metabolism
and immune function. Given the constant exposure of
the lungs to both metal-rich particles and microbes, we
evaluated localized expression and regulation of hepci-
din in the airway by inflammatory stimuli. We were able
to demonstrate that hepcidin was expressed locally by
airway epithelial cells, and that its expression can be
regulated by the pro-inflammatory cytokine IFN-g via
activation of STAT1. However, while IFN-g induced
hepcidin gene expression, it was not associated with sig-
nificantly decreased Fpn expression at the cell surface.
Further, cellular iron accumulation in airway epithelial
cells and alveolar macrophages was not altered by the
presence of exogenous hepcidin using these experimen-
tal conditions.
The hepcidin peptide is predominantly synthesized in
the liver where it is released into the circulation to con-
trol systemic iron metabolism in response to serum iron
content and the presence of hypoxia or inflammation
[1,26,27]. Locally, hepcidin is expressed by a number of
cell types, including airway macrophages, monocytes,
cardiac myocytes, and neurons where it may be differ-
entially regulated, likely reflecting the need to locally
control iron transport due to infection, ischemia, or
iron accumulation [7,9-11,26]. Here, we found that hep-
cidin was expressed by airway epithelial cells and was
induced by both IFN-g and IL-6 in a cell-specific pat-
tern. While response to IL-6 has been established in a
number of cell types [10,26], hepcidin induction by
IFN-g alone has not been reported. Hepcidin expression
in response to IFN-g demonstrated more prolonged
activation than the response to cytomix. This suggests
that the presence of TNF-a or IL-1b may serve a mod-
ulatory role in hepcidin regulation. This pattern is con-
sistent with that seen in blood monocytes and in
HepG2 cells where TNF-a had minimal effect on basal
expression of hepcidin, but significantly inhibited IL-6-
mediated hepcidin induction [28]. Our cells also showed
differential regulation of hepcidin in response to LPS.
Although LPS has been identified as a major regulator
of hepcidin in other cell types, including alveolar
macrophages and hepatocytes [7], we were unable to
detect a response in our NHBE cells despite the addi-
tion of CD14 to augment the ability of the airway
epithelial cells to respond to LPS [29].
We chose to study the regulation of hepcidin by IFN-g
in airway epithelial cells, because like hepcidin, IFN-g
provides an important link between immune response
and iron homeostasis. IFN-g acts as a principal affecter
of cell mediated immunity by promoting the internaliza-
tion of bacteria by macrophages and stimulating their
elimination. IFN-g decreases the expression of the trans-
ferrin receptor and ferritin [30,31] and thus, contributes
to antimicrobial defense by limiting iron availability.
IFN-g classically signals through the JAK-STAT pathway
[32], such that binding to the IFN-g receptor phosphory-
lates JAK2. Phosphorylated JAK2 subsequently phos-
phorylates and dimerizes STAT1, which translocates to
the nucleus. The hepcidin promoter has been reported
to contain a putative binding site for STAT proteins
[26]; therefore, we investigated IFN-g regulated hepcidin
expression via the JAK-STAT pathway through the acti-
vation of STAT1. We were able to demonstrate a
marked and sustained phosphorylation of JAK2 as well
as phosphorylation and nuclear translocation of STAT1
i nt h ep r e s e n c eo fI F N - g.F u r t h e r ,b l o c k i n gJ A K 2p h o s -
phorylation with the chemical inhibitor, AG490, partially
inhibited IFN-g-induced hepcidin expression, suggesting
that activation of STAT1 is required for full IFN-g-regu-
lated hepcidin gene expression in airway epithelial cells.
This is consistent with induction of hepcidin via STAT1
activation that has been described in a murine macro-
phage cell line [33]. The lack of complete inhibition of
IFN-g-induced hepcidin expression in our cells also
implies that additional signaling pathways are required
[ 3 4 ] .T h i si sr e m i n i s c e n to ft he coordinated transcrip-
tional activation of hepcidin in response to IL-6, which
requires activation of both the STAT3 and BMP-
response elements [35], and supports the idea that com-
plex transcriptional regulation of hepcidin is required
for precise coordination of iron availability in the face of
inflammation [36].
IFN-g is known to stimulate the production of pro-
inflammatory cytokines, including IL-6 [22,23]. Hepcidin
expression is strongly regulated by IL-6 in a number of
cell types [26,37]. We were able to demonstrate that
although IL-6 is capable of inducing IFN-g in our cells,
it does not contribute to IFN-g-mediated hepcidin
expression. Rather, IL-6-induced hepcidin expression
occurred much earlier than that mediated by IFN-g, sug-
gesting that these two inflammatory cytokines may pro-
vide a concerted response to infection [35,38], and thus
an additional means to fine tune the regulation of
hepcidin.
While IFN-g-responsive hepcidin expression was pre-
sent in airway epithelial cells, we were unable to demon-
strate a change in cell surface expression of Fpn or an
accumulation of total intracellular iron in the presence
of exogenous, biologically active hepcidin. The localized
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both airway epithelial cells and alveolar macrophages to
effectively scavenge excess iron from the airway and
sequester it from invading microbes. Given the role of
the Th1 cytokine, IFN-g in defense against intracellular
pathogens by macrophages [7,39], we next investigated
whether hepcidin produced by airway epithelial cells
acts on alveolar macrophages to coordinate iron seques-
tration. Again, we were unable to demonstrate changes
in total cellular iron accumulation in alveolar macro-
phages in the presence of exogenous hepcidin. The lack
of internalization of cell surface Fpn in macrophages in
response to hepcidin is consistent with previous investi-
gations. RAW264.7 cells treated with IFN-g together
with Salmonella typhimurium demonstrated increased
hepcidin gene expression but also increased Fpn gene
expression and an overall decrease in the cytoplasmic
iron content. Indeed, addition of exogenous transfer-
rin-bound iron to these infected macrophages resulted
in increased survival of the S. typhimurium [40].
Further, infected murine bone marrow macrophages
treated with exogenous hepcidin demonstrated interna-
lized cell surface Fpn, increased cellular iron retention,
a n de n h a n c e dg r o w t ho fi n t r a cellular organisms [41].
Bone marrow-derived macrophages and RAW264.7
macrophages have been reported to increase hepcidin
expression in response to IFN-g,b u to n l yi ns y n e r g y
with the intracellular organisms Mycobacterium avium
or M. tuberculosis. This increase in the hepcidin
expression was localized to mycobacterium-containing
phagosomes [10]. While iron transport was not mea-
sured in these cells, the authors demonstrate direct
antimicrobial activity by lysis of the mycobacterium
[10]. This suggests that cellular localization of hepcidin
in response to invading pathogens, which is not well
assessed by our methodology, is an important compo-
nent of the immune response of resident cells of the
airway.
Although the primary function of hepcidin is consid-
ered to be the regulation of iron homeostasis, hepcidin
was initially identified by its close structural and func-
tional resemblance to the defensin antimicrobial pep-
tides [3,15]. Hepcidin shares the common amphipathic
secondary structure and the net positive charge that are
displayed by defensins and other antimicrobial peptides.
This structure allows permeation of the membrane of
invading microorganisms and results in a broad spec-
trum of antimicrobial activity [3,15]. Inducible antimi-
crobial peptides are an important component of the
innate immune system. They are predominantly
expressed at epithelial surfaces where interactions with
the outside environment exist; this includes the airway
[16]. Similar to defensins, hepcidin has been shown to
provide direct killing of gram negative and gram positive
bacteria as well as fungi [15]. Therefore, the antimicro-
bial function of the hepcidin peptide may provide a
more direct mechanism for airway defense. Further
investigation is warranted to determine if increasing the
expression of hepcidin in the airway can provide direct
antimicrobial effect in vivo.
Conclusions
The airway is continually exposed to inhaled microbes
and environmental particulates and therefore must be
able to respond to local factors to impact iron metabo-
lism and immune function. To achieve this, epithelial
cells and macrophages of the lung have developed coor-
dinated defense mechanisms that include mucociliary
clearance, modulation of macrophage activation, and
secretion of antimicrobial peptides [42,43]. Here we
have demonstrated that airway epithelial cells express
the iron regulatory peptide hepcidin in response to IFN-
g and IL-6. Hepcidin has been identified as a peptide
that serves as both a regulator of iron homeostasis and
an antimicrobial peptide. In our study, we could not
demonstrate a direct effect of hepcidin on cellular iron
regulation under the conditions studied. However, as a
defensin-like molecule, hepcidin has a broad spectrum
of antimicrobial activity in addition to its iron regulatory
functions, which may provide an important anti-micro-
bial defense in the airway. Further study may be war-
ranted to determine the mechanism of hepcidin’sd i r e c t
anti-microbial effects and to determine if these effects
are impacted by altering cellular iron localization within
airway epithelial cells or macrophages.
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NHBE: Normal human bronchial epithelial cells; ALI: air
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